IMPLEMENTATION, MONITORING, EVALUATION AND LEARNING FRAMEWORK
Overview
The implementation of the NCCEAP will be tracked through three key approaches, as guided by the National Cancer Monitoring, Evaluation, Accountability and Learning Framework 2023-2027.
First, the implementation framework will be used to structure the proposed activities for every year into the annual workplans for all responsible agencies at national and county level.
Second, various indicators will be monitored on a continuous basis, to inform stakeholders on performance of the elimination initiative, and informing decision-making.
Lastly a mid-term evaluation will be conducted in 2028 and an end-term evaluation in 2031, to assess the extent of implementation and impact of the NCCEAP.
Second, various indicators will be monitored on a continuous basis, to inform stakeholders on performance of the elimination initiative, and informing decision-making.
Lastly a mid-term evaluation will be conducted in 2028 and an end-term evaluation in 2031, to assess the extent of implementation and impact of the NCCEAP.
Key outcome indicators for the NCCEAP derived from the National cancer control MEAL Framework
| Indicator | Baseline (2025) | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| Percentage of girls who have received the HPV vaccine by the age of 15 years | 54% | 70% | 80% | 90% | 90% | 90% |
| Percentage of women aged 30– 49 who have been screened with a high-performance test for the first time | 6% | 30% | 50% | 60% | 70% | 80% |
| Percentage of women identified with having pre-cancerous lesions that receive treatment | 43% | 60% | 70% | 80% | 90% | 90% |
| Percentage of women identified with having invasive cervical cancer that receive treatment | 58% | 60% | 70% | 75% | 80% | 90% |
| Proportion of women with cervical cancer who are diagnosed at early stage (stage 1 and 2) | 40% | 50% | 60% | 65% | 70% | 80% |
